Author Details

КАНЕСТРИ, Вероника Геннадиевна

Issue Section Title File
No 3 (2012) Articles THE NOVEL HIV NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR RILPIVIRINE: A REVIEW OF INTERNATIONAL CLINICAL TRIALS
No 1 (2013) Articles USE OF THE FUSION INHIBITOR ENFUVIRTIDE IN ANTIRETROVIRAL THERAPY REGIMENS FOR HIV-INFECTED PATIENTS
No 2 (2013) Articles THE HEPATITIS C VIRUS PROTEASE INHIBITOR TELAPREVIR IN THERAPY REGIMENS FOR CHRONIC HEPATITIS C IN PATIENTS WITH HIV INFECTION
No 6 (2013) Articles CONTRIBUTION OF A FIXED-DOSE ABACAVIR/LAMIVUDINE COMBINATION TO IMPROVING TREATMENT COMPLIANCE IN HIV-INFECTED PATIENTS
No 1 (2015) Articles Hepatotoxicity of antiretroviral therapy in HIV-infected patients
No 1 (2015) Articles A fixed-dose combination of abacavir/lamivudine as a nucleoside basis for first-line antiretroviral therapy regimens
No 2 (2015) Articles EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY REGIMENS CONTAINING ETRAVIRINE FOR HIV-INFECTED PATIENTS
No 6 (2015) Articles HIV drug resistance: Dolutegravir is a second-generation HIV integrase inhibitor
No 2 (2011) Articles THE HIV NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS ABACAVIR AND LAMIVUDINE IN FIRST-LINE ANTIRETROVIRAL THERAPY REGIMENS
Vol 10, No 3 (2020) Articles THE PROBLEM OF BODY WEIGHT GAIN IN HIV-INFECTED PATIENTS DURING ANTIRETROVIRAL THERAPY
Vol 10, No 4 (2020) Articles Impact of the organism’s genetic traits on the development of secondary and concomitant diseases in patients with HIV infection
Vol 11, No 3 (2021) Articles Results of treatment with a 60-week Russian ART regimen in patients with HIV infection
Vol 11, No 4 (2021) Articles The clinical course of HIV/ COVID-19 co-infection and approaches to its therapy
Vol 11, No 4 (2021) Articles Randomized, open-label, controlled, comparative study on switching HIV-infected patients with their antiretroviral therapy experience to a DTG and 3TC regimen: 96-weeks results
Vol 12, No 3 (2022) Articles Comparative analysis of clinical and laboratory outcomes in HIV-infected patients vaccinated and not vaccinated against COVID-19
Vol 12, No 3 (2022) Articles The efficiency and safety of ART after switching patients to the combined Russian NRTI phosphaladine in combination with elsulfavirine

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies